These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 4583975)

  • 1. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
    Lamon EW; Gatti RA; Kiessling R; Fenyö EM
    Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cell surface properties during the in vivo growth of Moloney lymphoma.
    Fenyö EM; Peebles PT; Wahlström A; Klein E; Cochran AJ
    Isr J Med Sci; 1973 Mar; 9(3):239-50. PubMed ID: 4575651
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of immune factors on the motility of lymphoma cells.
    Cochran AJ; Klein E; Keissling R
    J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH; Herberman RB; Nunn M; Soares N
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
    Herberman RB; Nunn ME; Lavrin DH; Asofsky R
    J Natl Cancer Inst; 1973 Nov; 51(5):1509-12. PubMed ID: 4543478
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
    Takeichi N; Austin FC; Oikawa T; Boone CW
    Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 12. The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.
    Fass L; Fefer A
    J Immunol; 1972 Oct; 109(4):749-53. PubMed ID: 5074330
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
    Bonavida B
    J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective impairment of cell antigenicity by fixation.
    Gatti RA; Ostborn A; Fagraeus A
    J Immunol; 1974 Oct; 113(4):1361-8. PubMed ID: 4213372
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 18. Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules.
    Fox RI; Weissman IL
    J Immunol; 1979 May; 122(5):1697-704. PubMed ID: 87439
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.
    Nabholz M; Vives J; Young HM; Meo T; Miggiano V; Rijnbeek A; Shreffler DC
    Eur J Immunol; 1974 May; 4(5):378-87. PubMed ID: 4277395
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.